Search
Search for:
Search for:
Find a Pharmacy
Vertice Login
Menu
About Us
About Us
Our Brand
What We Do
Our People
Contact Us
Careers
FAQ
Workers' Comp Solutions
Workers' Comp Solutions
Pharmacy
Ancillary
Clinical Services
Claims Technology
Claims Technology
Request Demo
Data Analytics
Insights
Insights
RxInformer
Worker's Comprehensive
Clinical Minute
Intelligence
Intelligence
Industry Insights Survey
Industry Insights Survey
2025
2024
2023
2022
2021
2020
2019
Blog
Infographics
Advocacy Compliance
What's Happening
What's Happening
Events
Medmonitor
Social Hub
Customer Center
Customer Center
Pharmacy Search
Ask a Pharmacist
Claims Resources
Claims Resources
Mail Order
Patient Resources
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Tag:
Opioids
27 posts found
Opioid Developments
Cebranopadol Phase 3 Trials Show Promising Results
A compound opioid/NOP receptor agonist demonstrated pain relief with a safety profile comparable to placebo.
Read More
Medmonitor
Generics Available for Lucemyra Tablets and Relistor Injection
These drugs treat opioid withdrawal and opioid-induced constipation, respectively.
Read More
Opioid Developments
New Opioid Prescribing and Abuse Data
NCCI hosted a recent webinar on opioid utilization, while Fair Health published a new Opioid Tracker tool to monitor state opioid data.
Read More
Clinical Insights
Massachusetts Publishes Study on Opioid Overdose Deaths
Approximately 741 injured workers died of opioid overdose deaths in Massachusetts.
Read More
Opioid Developments
FDA Approves First Test to Help Identify Risks of Developing Opioid Use Disorder
The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.
Read More
This Month's Must Read
Beyond Opioids: Drugs of Concern in Workers’ Compensation
As opioid utilization decreases, other pharmacy trends bear watching.
Read More
Opioid Developments
CDC Awards $279M to 49 States for Overdose Prevention
These funds will help states and communities respond more quickly, effectively, and equitably to prevent overdose death and injury.
Read More
Clinical Insights
Utilization of Opioid Use Disorder Medications
According to JAMA, only 22% of OUD patients received medication-assisted therapy.
Read More
Opioid Developments
FDA Approves Second OTC Naloxone Nasal Spray for Opioid Overdose
RiVive will soon be available without a prescription for the treatment of known or suspected opioid overdose.
Read More
Medmonitor
Brixadi Approved for Opioid Use Disorder
A new buprenorphine injection will be available for weekly or monthly dosages, administered by providers.
Read More
Industry Trends
Low-Volume, High Cost Medications in California
A new report from the CWCI highlights trends in dermatologicals, opioids, and antidepressants.
Read More
Opioid Developments
FDA to Update Prescribing Information for All Opioid Pain Medications
Changes to boxed warnings, indications and usage, dosage and administration, and more.
Read More
Marijuana Updates
More Research Indicates Marijuana Use May Reduce Opioid Use
New reports from the Journal of the American Medical Association and Health Economics.
Read More
Opioid Developments
Fentanyl Vaccine in Development
This vaccine blocks fentanyl from entering the brain and triggering euphoric effect.
Read More
Clinical Developments
CDC Publishes Updated Opioid Guidelines
An update to the 2016 guidelines has been issued, promoting greater flexibility for individualized patient-centered care.
Read More
1
2
Next
©
2025
Healthesystems
Workers' Comp Property and Casualty PBM
Expires 01/01/2028
info-circle
caret-right
lock
map-marker
magnifier
cross
menu
arrow-right
cross-circle